In brief: C3, SSH, Axon
Wednesday, 30 November, 2005
Clinical Cell Culture's (ASX:CCE) co-founder Prof Fiona Wood will step down from the company's board on December 31. She will remain as a consultant, an R&D partner through her research vehicle the McComb Foundation, and a substantial shareholder.
Shareholders at SSH Medical's (ASX:SSH) AGM yesterday approved a resolution to change the company's name to BioLayer Corporation, the unlisted Brisbane-based materials sciences company it acquired earlier this month.
Axon Instruments founder and former CEO Dr Alan Finkel has been appointed to the ATSE Clunies Ross board of governors. Finkel is the first winner of an ATSE Clunies Ross award to join the board.
Oxytocin analogue treats chronic abdominal pain
Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain,...
'Low-risk' antibiotic linked to rise of dangerous superbug
A new study has challenged the long-held belief that rifaximin — commonly prescribed to...
Robotic hand helps cultivate baby corals for reef restoration
The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...